Equities

Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals Inc

Actions
  • Price (MXN)958.00
  • Today's Change0.00 / 0.00%
  • Shares traded5.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Nov 04 2024 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2023, cash reserves at Rhythm Pharmaceuticals Inc fell by 67.60m. Cash Flow from Financing totalled 74.37m or 96.05% of revenues. In addition the company used 136.16m for operations while cash used for investing totalled 5.67m.
Cash flow per share-4.28
Price/Cash flow per share--
Book value per share2.49
Tangible book value per share2.38
More ▼

Balance sheet in USDView more

Rhythm Pharmaceuticals Inc has a Debt to Total Capital ratio of 41.71%, a lower figure than the previous year's 53.02%.
Current ratio3.49
Quick ratio3.34
Total debt/total equity0.7154
Total debt/total capital0.417
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.